Dow-DuPont Beset by Delays as EU Demands Missing Deal Info
(Bloomberg) -- Dow Chemical Co. and DuPont Co. face further delays to their plan to create the world's biggest chemical company after the European Commission demanded more information about the $59 billion tie-up.
The European Union's merger regulator “stopped the clock” in its in-depth investigation on Oct. 13, the watchdog said in an e-mail on Friday. This happens “if the parties do not provide an important piece of information that the commission has requested.”
Dow-DuPont, the first of a trio of mega-deals reshaping the agrichemicals industry, is embroiled in an extended probe by the EU over concerns that the combination may reduce competition for crop protection, seeds and some petrochemicals. The EU is separately examining China National Chemical Corp.'s bid for Switzerland's Syngenta AG.
The EU move is a re-run of a previous suspension that already delayed the regulator's Dow-DuPont probe by nearly a month. The extra suspension led analysts at Sanford C. Bernstein & Co. to lower the probability of the deal closing from 85 percent to 75 percent.
“While we still believe the deal should close, it is becoming increasingly probable that the” commission “is slow-walking this deal,” Jonas Oxgaard, a New York-based analyst at Bernstein said in a note. It “likely delays the closure of the deal date to sometime in late March 2017.”
Dow said in a statement Friday that it always expected a “thorough review” and both companies are working with the EU and other regulatory agencies. The deal is expected to close in the first quarter of 2017, the company said.
Dow fell as much as 0.6 percent and was down 0.3 percent at 1:44 p.m. in New York trading, while DuPont shares were little changed, erasing losses of as much as 0.5 percent.
Dow Chief Executive Officer Andrew Liveris said last month that the merger may be delayed until February from a planned closing late this year, as European antitrust officials take more time to consider potential competition issues in pesticides and crop seeds. Liveris said the value created by the deal made the wait worthwhile.
EU Competition Commissioner Margrethe Vestager has raised concerns that the agrichemicals industry is "quite concentrated already" and she'll ensure that farmers have affordable prices and a choice of providers. EU lawmakers and environmental campaigners have been calling on her to block Bayer AG's bid for Monsanto Co.
Regulators twice stopped the clock on their review of Halliburton Co.'s bid to buy oil-services rival Baker Hughes Inc. earlier this year, saying they needed more information from the companies. The firms abandoned the deal in May as the companies struggled to overcome antitrust concerns from the U.S., the EU and other regulators.
“Once the missing information is supplied by the parties, the clock is re-started and the deadline for the commission's decision is then adjusted accordingly,” the commission said.
To contact the reporter on this story: Stephanie Bodoni in Luxembourg at sbodoni@bloomberg.net. To contact the editors responsible for this story: Anthony Aarons at aaarons@bloomberg.net, Peter Chapman, Jack Kaskey
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
-
Everything, Everywhere, All At Once: Dalal Street's Week To Forget | Joining The Dots
Visa curbs, a Starlink spat and cancer drug caps: what connects this week's shocks for Indian markets
-
India Is Going Abroad For Critical Minerals. But It May Take Years To Pay Off | The Reason Why
Although India's steps are in the right direction, they remain modest compared with India's growing dependence.
-
When Everyone Has AI, What Gives You An Edge?
India's young workforce is entering an uncertain world of work where powerful AI tools are becoming widely accessible. The advantage will belong to those who combine deep expertise with digital fluency, and the distinctly human capabilities that technology cannot manufacture.
-
Wrong Labels, High Pesticide Residues Holding Back Agri Exports | The Reason Why
India needs stronger domestic food-safety and labelling standards, with best practices becoming part of everyday business for farmers, traders and food companies.